UnitedHealth (through Optum) wants to buy Amedisys, a major home health and hospice provider. Regulators say the deal could cut competition in many local markets, which can mean fewer choices and higher costs for seniors and families. Winning means stopping the merger or, if it moves forward, enforcing strong remedies that protect real competition.
No open cycle
This cause does not have an open cycle right now. Your grant status is still available in the dashboard.
Stop anticompetitive health care mergers
19
DAYS LEFT30,233
Votes
$66,547
Raised
$15,358
Sponsors
Regulators move to curb a major home-care deal
Why this matters now
Home health and hospice care often happen when people are sick, older, or near the end of life. Families need options they can trust, close to home.
When one large company controls more of the insurance side and the care side, competition can shrink in many communities. Less competition can lead to higher costs, fewer provider choices, and pressure on care quality and workers.
What's blocking progress
UnitedHealth has major legal and lobbying resources and argues the deal is a harmless “vertical” merger with efficiencies. If regulators or courts accept weaker settlements, competition in local markets may not be protected.
Strategies
Choose which strategies should receive funding this cycle.
0 grant votes available this cycle
Ballot edits are currently read only.
Community discussion
Start a discussion
Sign in to postDiscussion posting still runs on the legacy demo auth path and stays isolated from the Phase 1 Supabase backend.
- No threads yet. Be the first to post once the legacy discussion path is migrated.
Impact stories
Impact updates will appear here after the first cycle closes.